Illumina

Illumina is the global leader in next‑generation sequencing (NGS) and microarray platforms, offering benchtop systems (MiSeq, NextSeq) and high-throughput instruments (NovaSeq, MiSeq i100) for genomic, transcriptomic, and diagnostic applications.

Its compact MiSeq i100 series delivers results in as little as four hours, with instruments priced from $49K, making powerful in‑house sequencing more accessible.
Illumina’s instruments are widely used in both research and clinical labs worldwide.